Loading...
XHKG1666
Market cap808mUSD
Dec 23, Last price  
5.04HKD
1D
0.60%
1Q
0.00%
Jan 2017
-64.95%
Name

Tong Ren Tang Technologies Co.

Chart & Performance

D1W1MN
XHKG:1666 chart
P/E
9.99
P/S
0.87
EPS
0.47
Div Yield, %
3.23%
Shrs. gr., 5y
Rev. gr., 5y
6.01%
Revenues
6.77b
+13.04%
983,249,0001,135,678,0001,034,768,0001,157,030,0001,211,455,0001,307,897,0001,578,914,0001,936,418,0002,447,132,0002,910,749,0003,341,166,0004,066,960,0004,665,295,0005,025,183,0005,059,638,0004,476,449,0004,607,369,0005,400,487,0005,991,841,0006,773,463,000
Net income
590m
+1.25%
203,954,000231,186,000143,456,000153,520,000160,528,000173,027,000198,342,000254,687,000330,171,000390,093,000462,187,000540,481,000595,654,000666,666,000677,815,000417,650,000467,553,000507,249,000582,888,000590,188,000
CFO
554m
-23.43%
167,213,000164,654,000127,391,000-42,264,000115,851,000231,293,000266,837,000255,830,000401,648,000375,451,000333,875,000303,843,000410,005,000679,807,000985,236,0001,051,775,000435,810,0001,033,415,000723,769,000554,175,000
Dividend
Jun 14, 20240.19776 HKD/sh
Earnings
Mar 20, 2025

Profile

Tong Ren Tang Technologies Co. Ltd. manufactures and sells Chinese medicine products in Mainland China and Hong Kong. The company also cultivates, purchases, and sells Chinese medicinal raw materials; produces and sells ointment, tea drinks, and foot care products; sells medicinal products; and provides medical research and development, advertisement, and Chinese medical consultation and treatment services. In addition, it is involved in the technological development and sale of biological products, Chinese and Western medicines, cosmetics, and healthcare products; wholesale and retail sale of Chinese medicines and healthcare products; and internal and external surgery, medical examination, and hospital management activities. Further, it produces and processes biochemical products; extracts and processes plants; and produces food and daily chemical products, and medical services. The company was founded in 1669 and is based in Beijing, the People's Republic of China.
IPO date
Oct 31, 2000
Employees
4,030
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
6,773,463
13.04%
5,991,841
10.95%
5,400,487
17.21%
Cost of revenue
5,757,881
4,869,304
4,374,649
Unusual Expense (Income)
NOPBT
1,015,582
1,122,537
1,025,838
NOPBT Margin
14.99%
18.73%
19.00%
Operating Taxes
170,142
210,373
178,213
Tax Rate
16.75%
18.74%
17.37%
NOPAT
845,440
912,164
847,625
Net income
590,188
1.25%
582,888
14.91%
507,249
8.49%
Dividends
(202,909)
(204,925)
(204,925)
Dividend yield
2.42%
2.83%
1.91%
Proceeds from repurchase of equity
BB yield
Debt
Debt current
151,320
298,468
824,501
Long-term debt
1,647,006
1,344,413
883,030
Deferred revenue
132,584
112,534
151,346
Other long-term liabilities
(119,746)
(158,113)
Net debt
(2,481,649)
(2,582,401)
(2,218,619)
Cash flow
Cash from operating activities
554,175
723,769
1,033,415
CAPEX
(103,393)
(157,916)
(156,407)
Cash from investing activities
(1,067,527)
43,009
(197,363)
Cash from financing activities
(497,759)
(499,447)
(474,672)
FCF
158,361
435,827
910,085
Balance
Cash
4,237,936
4,182,500
3,887,783
Long term investments
42,039
42,782
38,367
Excess cash
3,941,302
3,925,690
3,656,126
Stockholders' equity
9,651,885
9,016,938
8,158,402
Invested Capital
7,470,381
6,643,983
6,198,226
ROIC
11.98%
14.21%
13.60%
ROCE
8.89%
10.61%
10.40%
EV
Common stock shares outstanding
1,280,784
1,280,784
1,280,784
Price
6.55
15.93%
5.65
-32.58%
8.38
68.61%
Market cap
8,389,135
15.93%
7,236,430
-32.58%
10,732,970
68.61%
EV
8,669,954
7,188,216
10,693,274
EBITDA
1,292,728
1,384,259
1,275,553
EV/EBITDA
6.71
5.19
8.38
Interest
45,053
53,798
61,796
Interest/NOPBT
4.44%
4.79%
6.02%